Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosorbide dinitrate and hydralazine in symptomatic systolic heart failure with pulmonary hypertension
ACTRN12608000030370Phase 4Not yet recruiting
- Sponsor
- Royal Melbourne Hospital
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of isosorbide dinitrate and hydralazine in heart failure (HF) and pulmonary hypertension (PH), sponsored by Royal Melbourne Hospital. Primary endpoint: Change in pulmonary artery pressure and left atrial pressure. Planned start Feb 2008; status: not yet recruiting.
02
Drugs
isosorbide dinitratehydralazine
03
Conditions
heart failure (HF)pulmonary hypertension (PH)
Beyond the preview
Go deeper on ACTRN12608000030370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000030370.